Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Antitumor Activity of a Selectively Replication Competent Herpes Simplex Virus (HSV) with Enzyme Prodrug Therapy

LYNNE BRAIDWOOD, PAUL D. DUNN, SUSAN HARDY, T.R. JEFFRY EVANS and S. MOIRA BROWN
Anticancer Research June 2009, 29 (6) 2159-2166;
LYNNE BRAIDWOOD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Lbraidwood@crusadelabs.co.uk
PAUL D. DUNN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUSAN HARDY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T.R. JEFFRY EVANS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. MOIRA BROWN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 6 2159-2166
PubMed 
19528476

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 11, 2008
  • Revision received December 18, 2009
  • Accepted January 29, 2009
  • Published online June 15, 2009.

Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. LYNNE BRAIDWOOD1,
  2. PAUL D. DUNN1,
  3. SUSAN HARDY1,
  4. T.R. JEFFRY EVANS2 and
  5. S. MOIRA BROWN1
  1. 1Crusade Laboratories Ltd, Department of Neurology, Southern General Hospital, Glasgow
  2. 2Centre for Oncology and Applied Pharmacology, University of Glasgow, Cancer Research UK Beatson Laboratories, Glasgow, U.K.
  1. Correspondence to: Lynne Braidwood, Crusade Laboratories Ltd, Dept of Neurology, Southern General Hospital, Govan Road, Glasgow, G51 4WF, U.K. Tel: +44 1414451716, Fax: +44 1414451715, e-mail: Lbraidwood{at}crusadelabs.co.uk
View Full Text

Cited By...

  • 15 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 29 (6)
Anticancer Research
Vol. 29, Issue 6
June 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antitumor Activity of a Selectively Replication Competent Herpes Simplex Virus (HSV) with Enzyme Prodrug Therapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Antitumor Activity of a Selectively Replication Competent Herpes Simplex Virus (HSV) with Enzyme Prodrug Therapy
LYNNE BRAIDWOOD, PAUL D. DUNN, SUSAN HARDY, T.R. JEFFRY EVANS, S. MOIRA BROWN
Anticancer Research Jun 2009, 29 (6) 2159-2166;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Antitumor Activity of a Selectively Replication Competent Herpes Simplex Virus (HSV) with Enzyme Prodrug Therapy
LYNNE BRAIDWOOD, PAUL D. DUNN, SUSAN HARDY, T.R. JEFFRY EVANS, S. MOIRA BROWN
Anticancer Research Jun 2009, 29 (6) 2159-2166;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
  • In Vivo Evaluation of a Cancer Therapy Strategy Combining HSV1716-Mediated Oncolysis with Gene Transfer and Targeted Radiotherapy
  • Google Scholar

More in this TOC Section

  • Effect of Chloroquine on Doxorubicin-induced Apoptosis in A549 Cells
  • Effect of Aspirin on G0/G1 Cell Cycle Arrest and microRNA Signatures in Pancreatic Adenocarcinoma Cells
  • Suppression of Inflammatory Cytokine Genes Expression in Vascular Endothelial Cells by Super-low Dose Lipopolysaccharide-activated Macrophages
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2022 Anticancer Research

Powered by HighWire